Outcome and prognostic factors of laparoscopic radical hysterectomy and pelvic lymphadenectomy in 148 patients with stage IB1 cervical cancer
- PMID: 22146764
- DOI: 10.1097/IGC.0b013e318233d549
Outcome and prognostic factors of laparoscopic radical hysterectomy and pelvic lymphadenectomy in 148 patients with stage IB1 cervical cancer
Abstract
Objective: To evaluate the surgical, oncological outcome and prognostic factors of laparoscopic radical hysterectomy (LRH) and pelvic lymphadenectomy in patients with stage IB1 cervical cancer.
Materials and methods: Patients with IB1 cervical cancer undergoing LRH at the First People's Hospital of Foshan between January 2000 and March 2010 were enrolled in this study. Follow-up data were available.
Results: A total of 148 patients were identified. One case converted to laparotomy. Median number of resected pelvic lymph nodes was 23. Median blood loss was 250 mL and median operative time was 257 minutes. Intraoperative and postoperative complications occurred in 5.4% and 6.75% patients, respectively. Other medical problems included 47 cases (31.75%) of bladder dysfunction. Twenty-seven patients (18.24%) had microscopic nodal metastasis. A total of 37 patients received adjuvant therapy. After a median follow-up of 28 months, 21 patients had a recurrence. The overall 5-year survival rate is 82%. Univariate analysis showed the factors affecting the survival rate were nonsquamous histologic type, high grade, deep cervical stromal invasion, lymphovascular space invasion, and lymph node metastasis (P = 0.016, P = 0.045, P = 0.021, P = 0.038, and P = <0.001). The Cox proportional hazards regression analysis indicated only lymph node metastasis (odds ratio = 6.293, P < 0.001) was an independent poor prognostic factor.
Conclusions: Laparoscopic radical hysterectomy can be a safe alternative to abdominal RH for patients with IB1 cervical cancer. Lymph node metastasis was an independent poor prognostic factor.
Similar articles
-
[Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].Zhonghua Fu Chan Ke Za Zhi. 2015 Dec;50(12):894-901. Zhonghua Fu Chan Ke Za Zhi. 2015. PMID: 26887872 Chinese.
-
Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.J Minim Invasive Gynecol. 2020 May-Jun;27(4):946-952. doi: 10.1016/j.jmig.2019.08.002. Epub 2019 Aug 5. J Minim Invasive Gynecol. 2020. PMID: 31394263
-
Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?Int J Gynecol Cancer. 2014 Jul;24(6):1072-6. doi: 10.1097/IGC.0000000000000163. Int J Gynecol Cancer. 2014. PMID: 24905616
-
Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer.Obstet Gynecol. 2003 Sep;102(3):612-9. doi: 10.1016/s0029-7844(03)00569-6. Obstet Gynecol. 2003. PMID: 12962952
-
Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2-IIA cervical cancer?Gynecol Oncol. 2012 Oct;127(1):102-6. doi: 10.1016/j.ygyno.2012.06.003. Epub 2012 Jun 7. Gynecol Oncol. 2012. PMID: 22683586 Review.
Cited by
-
Anatomical Description of Anterior Parametrium: A Probable Answer to Pelvic Recurrence Following Radical Hysterectomy.Indian J Surg Oncol. 2023 Jun;14(2):510-517. doi: 10.1007/s13193-023-01709-9. Epub 2023 Feb 24. Indian J Surg Oncol. 2023. PMID: 37324299 Free PMC article.
-
Radiographic Number of Positive Pelvic Lymph Nodes as a Prognostic Factor in Cervical Cancer Treated With Definitive Concurrent Chemoradiotherapy or Intensity-Modulated Radiotherapy.Front Oncol. 2018 Nov 30;8:546. doi: 10.3389/fonc.2018.00546. eCollection 2018. Front Oncol. 2018. PMID: 30555798 Free PMC article.
-
Morbidity after surgical management of cervical cancer in low and middle income countries: A systematic review and meta-analysis.PLoS One. 2019 Jul 3;14(7):e0217775. doi: 10.1371/journal.pone.0217775. eCollection 2019. PLoS One. 2019. PMID: 31269024 Free PMC article.
-
Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.Cancer Manag Res. 2021 Dec 29;13:9391-9400. doi: 10.2147/CMAR.S336892. eCollection 2021. Cancer Manag Res. 2021. PMID: 35002316 Free PMC article.
-
Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis.Med Sci Monit. 2022 Mar 9;28:e934588. doi: 10.12659/MSM.934588. Med Sci Monit. 2022. PMID: 35260545 Free PMC article.